Kidney Dialysis Patients: A Population At Undue Risk?

June 26, 2000

---

The focus of the hearing is to examine the quality of care ESRD patients receive. More specifically, the hearing will study the Health Care Finance Administration's role in implementing and overseeing the ESRD program in relationship to federally mandated quality standards and the ESRD Networks.

---

Date: June 26, 2000
Time: 1:30 p.m.
628 Dirksen

---

Statements of Committee Members

Senator Chuck Grassley, Chairman, Iowa

---

Witness Testimony Panel 1:

1. W. Kenneth Bays, D.D.S., Dialysis patient, Pelham, Georgia
   
   
2. Brent Smith, Dialysis patient, Chandler, Arizona
   
   
3. George Grob, Deputy Inspector General, Office of Inspector General, U.S. Department of Health and Human Services, Washington, DC
   
   
4. William Scanlon, Ph.D., Director Health Financing and Systems Issues, U.S. General Accounting Office, Washington, DC
   
   

Witness Testimony Panel 2:

1. Terry Bahr, President, National Renal Administrators Association (NRAA), Reston, Virginia
   
   
2. William F. Owen, Jr., M.D., President, Renal Physicians Association (RPA), Rockville, Maryland
   
   
3. Jay Wish, M.D., President, Forum of End Stage Renal Disease Networks, Midlothian, Virginia
   
   
4. Jeffrey L. Kang, M.D., Director, Office of Clinical Standards and Quality, Health Care Financing Administration, U.S. Department of Health and Human Services, Washington, DC
   
   

---

Hearing Publications

• Committee on Aging Print: 106-30

---